GNLKQ.US Genelink Inc

Healthcare Biotechnology USA Stocks
0.0000 USD
Close of Oct 17, 2026
Market cap
USD 10.6K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2013.

Is GNLKQ.US undervalued?

Graham number

The Graham number of Genelink Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Genelink Inc fundamental analysis

No fundamental analysis for Genelink Inc yet.

Genelink Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Genelink Inc

GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was incorporated in 1994 and is based in Orlando, Florida.

Full company profile